Literature DB >> 10523000

Serum leptin levels correlate with growth hormone secretion and body fat in children.

H Fors1, H Matsuoka, I Bosaeus, S Rosberg, K A Wikland, R Bjarnason.   

Abstract

The aim of this study was to investigate the relationship among GH secretion, leptin concentrations, and body composition measured with x-ray absorptiometry (DXA) in children. In total, 71 children were investigated, 51 males and 20 females. Their mean chronological age was 10.8 yr (range, 6.2-17.7 ys), and their mean height (SD) was -2.1 (0.63) SD scores. Their mean weight for height SD scores (WH(SDS)) was 0.2 (1.18). Body composition was investigated using DXA. Blood samples were taken for analysis of leptin, insulin-like growth factor I (IGF-I), IGF-binding protein-3, and 24-h GH secretion. A positive correlation was found between leptin and total body fat (r = 0.83; P < 0.0001) and when fat was expressed as a percentage of body weight (r = 0.86; P < 0.0001). There were significant (P < 0.0001) relationships between leptin and WH(SDS) (r = 0.45) and between leptin and body mass index (r = 0.69). A significant gender difference in leptin levels was found, but this disappeared after adjustment for body fat, as measured by DXA. There were significant (P < 0.001) inverse correlations between leptin and the AUCb for GH (r = -0.41), leptin, and GHmax (r = -0.38), where AUCb is the area under the curve above the calculated baseline, and GHmax is the maximum peak during the 24-h GH profile (percent fat and AUCb for GH, r = -0.43; percent fat and GHmax, r = -0.39). In a multiple stepwise forward regression analysis with leptin as the dependent variable, the percent trunk fat accounted for 77.7% of the leptin variation. With AUCb for GH as the dependent variable, the percent trunk fat accounted for 20.3% of the variation. With GHmax as the dependent variable, the percent trunk fat accounted for 18.8% of the variation, IGF-binding protein-3 for another 8.5%, and the percentage of fat from arms and legs for another 4.4%. We demonstrated a strong positive correlation between leptin levels and body fat, a significant negative correlation between leptin levels and GH secretion, and a significant negative correlation between body fat and GH secretion. We have also shown that specific regional fat depots have different relationships with leptin and particular markers of GH secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523000     DOI: 10.1210/jcem.84.10.6035

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum.

Authors:  Charumathi Baskaran; Kamryn T Eddy; Karen K Miller; Erinne Meenaghan; Madhusmita Misra; Elizabeth A Lawson
Journal:  Eur J Endocrinol       Date:  2016-04       Impact factor: 6.664

2.  Study of the leptin levels and its gene polymorphisms in patients with idiopathic short stature and growth hormone deficiency.

Authors:  Pen-Hua Su; Shun-Fa Yang; Ju-Shan Yu; Suh-Jen Chen; Jia-Yuh Chen
Journal:  Endocrine       Date:  2012-02-19       Impact factor: 3.633

3.  Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study.

Authors:  Anne Stuedal; Giske Ursin; Marit B Veierød; Yngve Bremnes; Janne E Reseland; Christian A Drevon; Inger T Gram
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

4.  Metabolic health assessment of zoo elephants: Management factors predicting leptin levels and the glucose-to-insulin ratio and their associations with health parameters.

Authors:  Kari A Morfeld; Janine L Brown
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

5.  Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects.

Authors:  Saimai Chatree; Chantacha Sitticharoon; Pailin Maikaew; Kitchaya Pongwattanapakin; Issarawan Keadkraichaiwat; Malika Churintaraphan; Chanakarn Sripong; Rungnapa Sririwichitchai; Sompol Tapechum
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.